↑ 123Pfaller M. A., Niles A. C., Murray P. R. In vitro antibacterial activity of cefpiramide. (англ.) // Antimicrobial Agents and Chemotherapy. — 1984. — Vol. 25, iss. 3. — P. 368–372. — ISSN1098-6596 0066-4804, 1098-6596. — doi:10.1128/AAC.25.3.368.
↑Hui Wang, Yingchun Yu, Xiuli Xie, Cangzhen Wang, Yuexian Zhang. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China (англ.) // Journal of Infection and Chemotherapy. — 2000. — Vol. 6, iss. 2. — P. 81–85. — doi:10.1007/PL00012156.
↑ 12Barry A. L., Jones R. N., Thornsberry C., Fuchs P. C., Ayers L. W. Cefpiramide: comparative in-vitro activity and β -lactamase stability (англ.) // Journal of Antimicrobial Chemotherapy. — 1985. — Vol. 16, iss. 3. — P. 315–325. — ISSN1460-2091 0305-7453, 1460-2091. — doi:10.1093/jac/16.3.315.
↑Demotes-Mainard F., Vincon G., Necciari J., Bertier M., Amouretti M. Pharmacokinetics of cefpiramide in patients with alcoholic cirrhosis and extrahepatic cholestasis (англ.) // European Journal of Pharmacology. — 1990. — Vol. 183, iss. 6. — P. 2299–2300. — doi:10.1016/0014-2999(90)93852-H.